Cargando…
When will tumor gene expression profiling be incorporated into clinical breast cancer decision making?
DNA microarray based gene expression analysis of primary breast cancers is not in general clinical use in spite of the widespread enthusiasm for the approach. However, several studies have identified gene expression patterns, or "signatures" that are predictive of disease outcome and assay...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779476/ https://www.ncbi.nlm.nih.gov/pubmed/16834787 http://dx.doi.org/10.1186/bcr1519 |